BIOMARKERS, PATHWAYS, AND TARGETED THERAPIES Trademark

Trademark Overview

On Sunday, January 1, 2012, a trademark application was filed for BIOMARKERS, PATHWAYS, AND TARGETED THERAPIES with the United States Patent and Trademark Office. The USPTO has given the BIOMARKERS, PATHWAYS, AND TARGETED THERAPIES trademark a serial number of 85507070. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 12, 2019. This trademark is owned by Intellisphere, LLC. The BIOMARKERS, PATHWAYS, AND TARGETED THERAPIES trademark is filed in the Advertising, Business and Retail Services category with the following description:

advertising services, namely, providing advertising space in magazines, journals, newsletters, articles, and web sites that concern information in the fields of medicine and healthcare
biomarkers, pathways, and targeted therapies

General Information

Serial Number85507070
Word MarkBIOMARKERS, PATHWAYS, AND TARGETED THERAPIES
Filing DateSunday, January 1, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 12, 2019
Registration Number4208042
Registration DateTuesday, September 11, 2012
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesadvertising services, namely, providing advertising space in magazines, journals, newsletters, articles, and web sites that concern information in the fields of medicine and healthcare

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 12, 2019
Primary Code035
First Use Anywhere DateFriday, July 27, 2012
First Use In Commerce DateFriday, July 27, 2012

Trademark Owner History

Party NameIntellisphere, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCranbury, NJ 08512
Party NameIntellisphere, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPlainsboro, NJ 08536

Trademark Events

Event DateEvent Description
Wednesday, January 4, 2012NEW APPLICATION ENTERED
Monday, January 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 30, 2012ASSIGNED TO EXAMINER
Friday, April 6, 2012NON-FINAL ACTION WRITTEN
Friday, April 6, 2012NON-FINAL ACTION E-MAILED
Friday, April 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 27, 2012TEAS AMENDMENT OF USE RECEIVED
Saturday, July 28, 2012USE AMENDMENT FILED
Saturday, July 28, 2012AMENDMENT TO USE PROCESSING COMPLETE
Friday, July 27, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 2, 2012ASSIGNED TO LIE
Thursday, August 2, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 2, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 2, 2012USE AMENDMENT ACCEPTED
Friday, August 3, 2012NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, August 3, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, August 3, 2012EXAMINERS AMENDMENT E-MAILED
Friday, August 3, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 3, 2012EXAMINER'S AMENDMENT ENTERED
Friday, August 3, 2012APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, August 6, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 11, 2012REGISTERED-SUPPLEMENTAL REGISTER
Monday, May 25, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, January 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, January 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 11, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 12, 2019CANCELLED SEC. 8 (6-YR)
Thursday, October 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

therapies targeted pathways biomarkers advertising concern sites information fields healthcare medicine articles newsletters namely